Literature DB >> 3777683

Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass. Association with lung neutrophil sequestration and tissue peroxidation.

S Braude, K B Nolop, J S Fleming, T Krausz, K M Taylor, D Royston.   

Abstract

We examined the hypothesis that increased pulmonary transvascular protein flux after cardiopulmonary bypass (CPB) is mediated in part by neutrophil-derived, oxygen-free radicals. Measurements of transvascular lung 113mIn-transferrin flux, transpulmonary neutrophil counts, and plasma concentrations of thiobarbituric acid (TBA) reactive substances were made in 8 dogs after CPB and in 6 dogs who underwent thoracotomy alone. The TBA reactivity is indicative of lipid peroxidation and was used as an index of oxygen-free radical release. All 14 dogs had a baseline measurement of lung protein flux 1 wk prior to thoracotomy. In the bypass dogs, lung protein flux was -0.2 +/- 0.3 protein flux units (mean +/- SEM) at baseline and increased significantly after bypass to 3.3 +/- 1.0 (p less than 0.01). The control thoracotomy group had baseline values similar to the baseline studies in the CPB dogs (0.2 +/- 0.3 units), but no significant difference was noted after thoracotomy. The CPB dogs showed initial significant parallel falls in left atrial (LA) and central venous (CV) neutrophil counts during bypass (baseline, 5.3 +/- 0.7 X 10(9) cells/L in both sample sites, falling to 3.0 +/- 0.5 and 2.9 +/- 0.5, respectively, p less than 0.001), but a significant CV-LA transpulmonary gradient existed only when pulmonary perfusion recommenced after a period of total asystole. Concentration of TBA reactive substances increased significantly during the course of bypass (baseline LA, 6.4 +/- 0.5 nmol/L, baseline CV, 6.4 +/- 0.5, increasing to 9.8 +/- 1.0 and 9.4 +/- 1.6 at the end of bypass, respectively, p less than 0.01), but likewise, there was a significant transpulmonary gradient only after reversal of asystole.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3777683     DOI: 10.1164/arrd.1986.134.5.867

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  NO news is good news.

Authors:  M Sair; T W Evans
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

2.  Cardiorespiratory dynamics during successful and unsuccessful trials of weaning from mechanical ventilation following cardiac surgery.

Authors:  Yoshinori Nishiyama; Masaharu Ito
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

3.  Extracorporeal membrane oxygenation induced cardiac dysfunction in newborn lambs.

Authors:  Lee A Pyles; Robert A Gustafson; James Fortney; Stanley Einzig
Journal:  J Cardiovasc Transl Res       Date:  2010-09-17       Impact factor: 4.132

4.  Oxygen consumption after cardiopulmonary bypass--implications of different measuring methods.

Authors:  H M Oudemans-van Straaten; G J Scheffer; L Eysman; C R Wildevuur
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

5.  Plasma histamine profiles in paediatric cardiopulmonary bypass.

Authors:  A Marath; W Man; K M Taylor; P B Deverall; S Parsons; O H Jones; C Lincoln; A Kimberley
Journal:  Agents Actions       Date:  1988-04

6.  Cardiopulmonary bypass during cardiac surgery modulates systemic inflammation by affecting different steps of the leukocyte recruitment cascade.

Authors:  Jan Rossaint; Christian Berger; Hugo Van Aken; Hans H Scheld; Peter K Zahn; Andreas Rukosujew; Alexander Zarbock
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

7.  Shear stress associated with cardiopulmonary bypass induces expression of inflammatory cytokines and necroptosis in monocytes.

Authors:  Lan N Tu; Lance Hsieh; Masaki Kajimoto; Kevin Charette; Nataliya Kibiryeva; Adriana Forero; Sarah Hampson; Jennifer A Marshall; James O'Brien; Marta Scatena; Michael A Portman; Ram Savan; Chris Benner; Alberto Aliseda; Muhammad Nuri; Douglas Bittel; Peter Pastuszko; Vishal Nigam
Journal:  JCI Insight       Date:  2021-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.